Comparison of rescue medication prescriptions in patients with chronic obstructive pulmonary disease receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol in routine clinical practice in England

Purpose: Routinely collected healthcare data on the comparative effectiveness of the long-acting muscarinic antagonist/long-acting β2-agonist combination umeclidinium/vilanterol (UMEC/VI) versus tiotropium bromide/olodaterol (TIO/OLO) for chronic obstructive pulmonary disease (COPD) is limited. This...

Full description

Saved in:
Bibliographic Details
Main Authors: Requena, Gema (Author) , Czira, Alexandrosz (Author) , Banks, Victoria (Author) , Wood, Robert (Author) , Tritton, Theo (Author) , Castillo, Catherine M. (Author) , Yeap, Jie (Author) , Wild, Rosie (Author) , Compton, Chris (Author) , Rothnie, Kieran J. (Author) , Herth, Felix (Author) , Quint, Jennifer K. (Author) , Ismaila, Afisi S. (Author)
Format: Article (Journal)
Language:English
Published: 2023
In: The International journal of chronic obstructive pulmonary disease
Year: 2023, Volume: 18, Pages: 1431-1444
ISSN:1178-2005
DOI:10.2147/COPD.S411437
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.2147/COPD.S411437
Verlag, kostenfrei, Volltext: https://www.dovepress.com/comparison-of-rescue-medication-prescriptions-in-patients-with-chronic-peer-reviewed-fulltext-article-COPD
Get full text
Author Notes:Gema Requena, Alexandrosz Czira, Victoria Banks, Robert Wood, Theo Tritton, Catherine M. Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J. Rothnie, Felix Herth, Jennifer K. Quint, Afisi S. Ismaila

MARC

LEADER 00000caa a2200000 c 4500
001 1857223276
003 DE-627
005 20240307060438.0
007 cr uuu---uuuuu
008 230822s2023 xx |||||o 00| ||eng c
024 7 |a 10.2147/COPD.S411437  |2 doi 
035 |a (DE-627)1857223276 
035 |a (DE-599)KXP1857223276 
035 |a (OCoLC)1425212768 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Requena, Gema  |e VerfasserIn  |0 (DE-588)1299849806  |0 (DE-627)1857224140  |4 aut 
245 1 0 |a Comparison of rescue medication prescriptions in patients with chronic obstructive pulmonary disease receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol in routine clinical practice in England  |c Gema Requena, Alexandrosz Czira, Victoria Banks, Robert Wood, Theo Tritton, Catherine M. Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J. Rothnie, Felix Herth, Jennifer K. Quint, Afisi S. Ismaila 
264 1 |c 2023 
300 |b Illustrationen 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 13. Juli 2023 
500 |a Gesehen am 22.08.2023 
520 |a Purpose: Routinely collected healthcare data on the comparative effectiveness of the long-acting muscarinic antagonist/long-acting β2-agonist combination umeclidinium/vilanterol (UMEC/VI) versus tiotropium bromide/olodaterol (TIO/OLO) for chronic obstructive pulmonary disease (COPD) is limited. This study compared rescue medication prescriptions in patients with COPD in England receiving UMEC/VI versus TIO/OLO. Patients and Methods: This retrospective cohort study used primary care data from the Clinical Practice Research Datalink Aurum database linked with secondary care administrative data from Hospital Episode Statistics. Patients with a COPD diagnosis at age ≥ 35 years were included (indexed) following initiation of single-inhaler UMEC/VI or TIO/OLO between July 1, 2015, and September 30, 2019. Outcomes included the number of rescue medication prescriptions at 12-months (primary), and at 6-, 18- and 24-months (secondary), adherence at 6-, 12-, 18- and 24-months post-index, defined as proportion of days covered ≥ 80% (secondary), and time-to-initiation of triple therapy (exploratory). Inverse probability of treatment weighting (IPTW) was used to balance potential confounding baseline characteristics. Superiority of UMEC/VI versus TIO/OLO for the primary outcome of rescue medication prescriptions was assessed using an intention-to-treat analysis with a p-value < 0.05. Results: In total, 8603 patients were eligible (UMEC/VI: n = 6536; TIO/OLO: n = 2067). Following IPTW, covariates were well balanced across groups. Patients initiating UMEC/VI had statistically significantly fewer (mean [standard deviation]; p-value) rescue medication prescriptions versus TIO/OLO in both the unweighted (4.84 [4.78] vs 5.68 [5.00]; p < 0.001) and weighted comparison (4.91 [4.81] vs 5.48 [5.02]; p = 0.0032) at 12 months; consistent results were seen at all timepoints. Adherence was numerically higher for TIO/OLO versus UMEC/VI at all timepoints. Time-to-triple therapy was similar between treatment groups. Conclusion: UMEC/VI was superior to TIO/OLO in reducing rescue medication prescriptions at 12 months after treatment initiation in a primary care cohort in England, potentially suggesting improvements in symptom control with UMEC/VI compared with TIO/OLO. 
700 1 |a Czira, Alexandrosz  |e VerfasserIn  |4 aut 
700 1 |a Banks, Victoria  |e VerfasserIn  |4 aut 
700 1 |a Wood, Robert  |e VerfasserIn  |4 aut 
700 1 |a Tritton, Theo  |e VerfasserIn  |4 aut 
700 1 |a Castillo, Catherine M.  |e VerfasserIn  |4 aut 
700 1 |a Yeap, Jie  |e VerfasserIn  |4 aut 
700 1 |a Wild, Rosie  |e VerfasserIn  |4 aut 
700 1 |a Compton, Chris  |e VerfasserIn  |4 aut 
700 1 |a Rothnie, Kieran J.  |e VerfasserIn  |4 aut 
700 1 |a Herth, Felix  |e VerfasserIn  |0 (DE-588)1016095236  |0 (DE-627)705477568  |0 (DE-576)351509925  |4 aut 
700 1 |a Quint, Jennifer K.  |e VerfasserIn  |4 aut 
700 1 |a Ismaila, Afisi S.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t The International journal of chronic obstructive pulmonary disease  |d Albany, Auckland : DOVE Medical Press, 2006  |g 18(2023), Seite 1431-1444  |h Online-Ressource  |w (DE-627)504104357  |w (DE-600)2212419-6  |w (DE-576)312706367  |x 1178-2005  |7 nnas  |a Comparison of rescue medication prescriptions in patients with chronic obstructive pulmonary disease receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol in routine clinical practice in England 
773 1 8 |g volume:18  |g year:2023  |g pages:1431-1444  |g extent:14  |a Comparison of rescue medication prescriptions in patients with chronic obstructive pulmonary disease receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol in routine clinical practice in England 
856 4 0 |u https://doi.org/10.2147/COPD.S411437  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.dovepress.com/comparison-of-rescue-medication-prescriptions-in-patients-with-chronic-peer-reviewed-fulltext-article-COPD  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20230822 
993 |a Article 
994 |a 2023 
998 |g 1016095236  |a Herth, Felix  |m 1016095236:Herth, Felix  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PH1016095236  |e 950000PH1016095236  |e 950900PH1016095236  |e 50000PH1016095236  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 11 
999 |a KXP-PPN1857223276  |e 436909268X 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Gema Requena, Alexandrosz Czira, Victoria Banks, Robert Wood, Theo Tritton, Catherine M. Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J. Rothnie, Felix Herth, Jennifer K. Quint, Afisi S. Ismaila"]},"recId":"1857223276","language":["eng"],"title":[{"title_sort":"Comparison of rescue medication prescriptions in patients with chronic obstructive pulmonary disease receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol in routine clinical practice in England","title":"Comparison of rescue medication prescriptions in patients with chronic obstructive pulmonary disease receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol in routine clinical practice in England"}],"id":{"eki":["1857223276"],"doi":["10.2147/COPD.S411437"]},"physDesc":[{"noteIll":"Illustrationen","extent":"14 S."}],"origin":[{"dateIssuedDisp":"2023","dateIssuedKey":"2023"}],"relHost":[{"recId":"504104357","titleAlt":[{"title":"International journal of COPD"}],"language":["eng"],"title":[{"title_sort":"International journal of chronic obstructive pulmonary disease","title":"The International journal of chronic obstructive pulmonary disease"}],"part":{"year":"2023","volume":"18","extent":"14","pages":"1431-1444","text":"18(2023), Seite 1431-1444"},"pubHistory":["1.2006 -"],"id":{"issn":["1178-2005"],"zdb":["2212419-6"],"eki":["504104357"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Comparison of rescue medication prescriptions in patients with chronic obstructive pulmonary disease receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol in routine clinical practice in EnglandThe International journal of chronic obstructive pulmonary disease","origin":[{"publisher":"DOVE Medical Press","dateIssuedKey":"2006","dateIssuedDisp":"2006-","publisherPlace":"Albany, Auckland"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 02.11.09"]}],"note":["Veröffentlicht: 13. Juli 2023","Gesehen am 22.08.2023"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"role":"aut","display":"Requena, Gema","family":"Requena","given":"Gema"},{"role":"aut","display":"Czira, Alexandrosz","family":"Czira","given":"Alexandrosz"},{"role":"aut","display":"Banks, Victoria","family":"Banks","given":"Victoria"},{"role":"aut","display":"Wood, Robert","family":"Wood","given":"Robert"},{"role":"aut","display":"Tritton, Theo","family":"Tritton","given":"Theo"},{"family":"Castillo","given":"Catherine M.","role":"aut","display":"Castillo, Catherine M."},{"role":"aut","display":"Yeap, Jie","family":"Yeap","given":"Jie"},{"family":"Wild","given":"Rosie","role":"aut","display":"Wild, Rosie"},{"given":"Chris","family":"Compton","display":"Compton, Chris","role":"aut"},{"role":"aut","display":"Rothnie, Kieran J.","family":"Rothnie","given":"Kieran J."},{"family":"Herth","given":"Felix","role":"aut","display":"Herth, Felix"},{"family":"Quint","given":"Jennifer K.","role":"aut","display":"Quint, Jennifer K."},{"role":"aut","display":"Ismaila, Afisi S.","family":"Ismaila","given":"Afisi S."}]} 
SRT |a REQUENAGEMCOMPARISON2023